Browsing Wolfson Institute of Preventive Medicine by Author "Staebler, A"
Now showing items 1-3 of 3
-
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.
Krämer, P; Talhouk, A; Brett, MA; Chiu, DS; Cairns, ES; Scheunhage, DA; Hammond, RFL; Farnell, D; Nazeran, TM; Grube, M (2020-10-15)PURPOSE: Endometrioid ovarian carcinoma (ENOC) is generally associated with a more favorable prognosis compared with other ovarian carcinomas. Nonetheless, current patient treatment continues to follow a "one-size-fits-all" ... -
Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany
Iftner, T; Becker, S; Neis, K-J; Castanon, A; Iftner, A; Holz, B; Staebler, A; Henes, M; Rall, K; Haedicke, J (2015-08) -
Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany.
Iftner, T; Neis, K-J; Castanon, A; Landy, R; Holz, B; Woll-Herrmann, A; Iftner, A; Staebler, A; Wallwiener, D; Hann von Weyhern, C (2019-01)Longitudinal data on the E6/E7 mRNA-based Aptima human papillomavirus (AHPV) assay exceeding three years in comparison to the gold standard Digene Hybrid Capture 2 (HC2) test are not available. We previously reported the ...